Vaccine against varicella-zoster virus
US4686101A · kind A · utility
12Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 1985 |
| Grant date | Aug 11, 1987 |
| Priority date | — |
| Expiry date | Aug 2, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/224
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A gene of varicella-zoster virus (VZV) which encodes immunogenic outer surface viral proteins has been identified by DNA sequence analysis. This gene can hybrid select messenger RNA which encodes and expresses a protein which reacts with human canvalescent zoster sera and with polyclonal monospecific antisera which neutralize viral infectivity. These proteins are useful for the preparation of a vaccine for VZV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.